CXCL12 Chemokine Up-Regulates Bone Resorption and MMP-9 Release by Human Osteoclasts: CXCL12 Levels Are Increased in Synovial and Bone Tissue of Rheumatoid Arthritis Patients

Journal of Cellular Physiology

Volumn 199, Issue 2, 2004, Pages 244-251

  Grassi, Francesco ^a   Cristino, Sandra ^a   Toneguzzi, Stefania ^a   Piacentini, Anna ^a   Facchini, Andrea ^a,b   Lisignoli, Gina ^a,c  

^a Laboratorio di Immunologia e Genetica   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALPHA CHEMOKINE; CD11B ANTIGEN; COLONY STIMULATING FACTOR 1; GELATINASE B; OSTEOCLAST DIFFERENTIATION FACTOR; STROMAL CELL DERIVED FACTOR 1; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ARTICLE; BONE BIOPSY; BONE TISSUE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INFLAMMATION; OSTEOARTHRITIS; OSTEOCLAST; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM; RHEUMATOID ARTHRITIS; STAINING; SYNOVIUM; UPREGULATION;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BONE AND BONES; BONE RESORPTION; CELL DIFFERENTIATION; CHEMOKINES, CXC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 9; OSTEOARTHRITIS; OSTEOCLASTS; SYNOVIAL MEMBRANE; UP-REGULATION;

EID: 1842473704     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10445     Document Type: Article

References (35)

1. Baggiolini M. 2001. Chemokines in pathology and medicine. J Intern Med 2001:91-104.
2. Blades MC, Ingegnoli F, Wheller SK, Manzo A, Wahid S, Panayi GS, Perretti M, Pitzalis C. 2002. Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID mice. Arthritis Rheum 46:824-836.
3. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, Salmon M. 2000. Persistent induction of the chemochine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 165:3423-3429.
4. Burger JA, Zvaifer NJ, Tsukada N, Firestein GS, Kipps TJ. 2001. Fibroblast-like synoviocytes support B-cell pseudoemperipolesis via a stromal cell-derived factor-1- and CD106 (VCAM-1)-dependent mechanism. J Clin Invest 107:305-315.
5. Choi SJ, Oba Y, Gazit Y, Alsina M, Cruz J, Anderson J, Roodman GD. 2001. Antisense inhibition of macrophage inflammatory protein 1-alpha blocks bone destruction in a model of myeloma bone disease. J Clin Invest 108:1833-1841.
6. Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, Quinn M, Karim Z, Green MJ, Proudman S, Isaacs J, Emery P. 2003. Elucidation of the relationship between synovitis and bone damage. A randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 48:64-71.
7. Feldmann M, Brennan FM, Maini RN. 1996. Rheumatoid arthritis. Cell 85:307-310.
8. Gravallese EM, Harada Y, Wang JT, Gorn AH, Thornhill TS, Goldring SR. 1998. Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis. Am J Pathol 152:943-951.
9. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR. 2000. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 43:250-258.
10. Graves DT, Alsulaimani F, Ding Y, Marks SC. 2002. Developmentally regulated monocyte recruitment and bone resorption are modulated by functional deletion of the monocytic chemoattractant protein-1 gene. Bone 31:282-287.
11. Hecht I, Cahalon L, Hershkoviz R, Lahat A, Franitza S, Lider O. 2003. Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: Inhibition of cellular signaling, adhesion and chemotaxis. Int Immunol 15:29-38.
12. Highton J, Carlisle B, Palmer DG. 1995. Changes in the phenotype of monocytes/macrophages and expression of cytokine mRNA in peripheral blood and synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 102:541-546.
13. Kanbe K, Takagishi K, Chen Q. 2002. Stimulation of matrix metalloprotease 3 release from human chondrocytes by the interaction of stromal cell-derived factor 1 and CXC chemokine receptor 4. Arthritis Rheum 46:130-137.
14. Klier CM, Nelson EL, Cohen CD, Horuk R, Schlondorff D, Nelson PJ. 2001. Chemokine-induced secretion of gelatinase B in primary human monocytes. Biol Chem 382:1405-1410.
15. Lisignoli G, Piacentini A, Toneguzzi S, Grassi F, Cocchini B, Ferruzzi A, Gualtieri G, Facchini A. 2000. Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M. Clin Exp Immunol 119:346-353.
16. Mellado M, Rodriguez-Rade JM, Villa-Coro AJ, Fernandez SA, Martin de Ana A, Jones MR, Martinez-A C. 2001. Chemokine receptor homo- and heterodimerization activates distinct signaling pathways. EMBO J 20:2497-2507.
17. Murdoch C. 2000. CXCR4: Chemokine receptor extraordinary. Immunol Rev 177:175-184.
18. Nagasawa T, Hirota S, Tachibana K, Takamura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T. 1996. Defects of B-cell lymphopoiesis and bone-marrow myelopoies in mice lacking the CXC chemokine PBSF/SDF-1. Nature 382:635-638.
19. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE. 2000. Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 165:6590-6598.
20. Nielsen H, Petersen AA, Skjodt H, Horslev-Petersen K, Bendtzen K. 1999. Blood levels of CD11b+ memory T lymphocytes are selectivel upregulated in patients with active rheumatoid arthritis. APMIS 107:1124-1130.
21. Okada Y, Naka K, Kawamura K, Matsumoto T, Nakanishi I, Fujimo N, Sato H, Seiki M. 1995. Localization of matrix metalloproteinase 9 (92-kiloDalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab Invest 72:311-322.
22. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ. 2003. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immunol 170:2147-2152.
23. Poznansky MC, Olszak IT, Foxxal R, Evans RH, Luster AD, Scadden DT. 2000. Active movement of T cells away from a chemokine. Nat Med 6:543-548.
24. Redlich K, Hayer S, Maier A, Dunstan CR, Tohidast-Akrad M, Lang S, Kollias G, Pietschmann P, Woloszczuk W, Haralambous S, Steiner G, Smolen JS, Schett G. 2002. Tumor necrosis factor α-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum 46:785-792.
25. Redlich K, Hayer S, Ricci R, David JP, Tohidast-Akrad M, Kollias G, Steiner G, Smolen JS, Wagner EF, Schett G. 2002. Osteoclasts are essential for TNF-α-mediated joint destruction. J Clin Invest 110:1419-1427.
26. Ritchlin CT, Haas-Smith SA, Li P, Hicks DG, Schwarz EM. 2003. Mechanisms of TNF-α- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J Clin Invest 111:821-831.
27. Romas E, Bakharevski O, Hards DK, Kartsogiannis V, Quinn JMW, Ryan PFJ, Martin TJ, Gillespie MT. 2000. Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis. Arthritis Rheum 43:821-826.
28. Scheven BA, Milne JS, Hunter I, Robins SP. 1999. Macrophage-inflammatory protein-lalpha regulates preosteoclast differentiation in vitro. Biochem Biophys Res Commun 254:773-778.
29. Scott DL, Pugner K, Kaarela K, Doyle DV, Woolf A, Holmes J, Hieko K. 2000. The links between joint damage and disability in rheumatoid arthritis. Rheumatology 39:122-132.
30. Shadidi KR, Aarvak T, Henriksen JE, Natvig JB, Thompson KM. 2003. The chemokines CCL5, CCL2 and CXCL12 play significant roles in the migration of Th1 cells into rheumatoid synovial tissue. Scand J Immunol 57:192-198.
31. Shalhoub V, Elliott G, Chiu L, Manoukian R, Kelley M, Hawkins N, Davy E, Shimamoto G, Beck J, Kaufman SA, Van G, Scully S, Qi M, Grisanti M, Dunstan C, Boyle WJ, Lacey DL. 2000. Characterization of osteoclast precursors in human blood. Br J Haematol 111:501-512.
32. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S. 2000. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 43:2523-2530.
33. Szekanecz Z, Kim J, Koch AE. 2003. Chemokines and chemokines receptors in rheumatoid arthritis. Semin Immunol 15:15-21.
34. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, Koshihara Y, Oda H, Nakamura K, Tanaka S. 2000. Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritits. Arthritis Rheum 43:259-269.
35. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chodroctyes. Cell 93:411-422.